Cargando…

Lower circulating platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma

BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) mortality rates have not shown significant reduction in decades. Platelets are being implicated in having cancer-promoting roles, an observation supported by the adverse outcomes associated with thrombocytosis in many malignancies associated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rachidi, Saleh, Wallace, Kristin, Day, Terry A, Alberg, Anthony J, Li, Zihai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189675/ https://www.ncbi.nlm.nih.gov/pubmed/25260646 http://dx.doi.org/10.1186/s13045-014-0065-5

Ejemplares similares

Lower platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma: a retrospective analysis
por: Furlan, Carlo, et al.
Publicado: (2015)

Circulating primers enhance platelet function and induce resistance to antiplatelet therapy
por: Blair, T A, et al.
Publicado: (2015)

Circulating and Platelet MicroRNAs in Cardiovascular Risk Assessment and Antiplatelet Therapy Monitoring
por: Procyk, Grzegorz, et al.
Publicado: (2022)

Prognosis Value of Platelet Counts, Albumin and Neutrophil-Lymphocyte Ratio of Locoregional Recurrence in Patients with Operable Head and Neck Squamous Cell Carcinoma
por: Ye, Jing, et al.
Publicado: (2020)

Independent association of Lp(a) with platelet reactivity in subjects without statins or antiplatelet agents
por: Liu, Huixing, et al.
Publicado: (2022)

Independent association of PCSK9 with platelet reactivity in subjects without statin or antiplatelet agents
por: Wang, Shuai, et al.
Publicado: (2022)

Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma
por: Brandt, Anna, et al.
Publicado: (2023)

Platelets: Pathophysiology and Antiplatelet Drug Therapy
por: Snyder, Edward L.
Publicado: (1983)

Improved outcomes after radiotherapy for prostate cancer: Anticoagulation, antiplatelet therapy, and platelet count as key factors in disease progression
por: Gutiontov, Stanley I., et al.
Publicado: (2020)

Platelet Function Testing-Guided Antiplatelet Therapy
por: Lenk, Ekaterina, et al.
Publicado: (2014)

Rethinking the Use of Routine Platelet Transfusions for Head Injured Patients on Antiplatelet Therapy
por: Ologun, Gabriel O, et al.
Publicado: (2019)

Circulating Tumor Cells Correlate With Prognosis in Head and Neck Squamous Cell Carcinoma
por: Zhou, Shichao, et al.
Publicado: (2021)

Individualized circulating tumor DNA monitoring in head and neck squamous cell carcinoma
por: Kogo, Ryunosuke, et al.
Publicado: (2022)

Molecular Profiling of Multiple Human Cancers Defines an Inflammatory Cancer-Associated Molecular Pattern and Uncovers KPNA2 as a Uniform Poor Prognostic Cancer Marker
por: Rachidi, Saleh M., et al.
Publicado: (2013)

Correction: Molecular Profiling of Multiple Human Cancers Defines an Inflammatory Cancer-Associated Molecular Pattern and Uncovers KPNA2 as a Uniform Poor Prognostic Cancer Marker
por: Rachidi, Saleh M., et al.
Publicado: (2014)

Counting on better health?
por: Purvis, John
Publicado: (2015)

An assessment of racial differences in epidemiological, clinical and psychosocial factors among head and neck cancer patients at the time of surgery
por: Kompelli, Anvesh, et al.
Publicado: (2020)

Pretreatment monocyte counts and neutrophil counts predict the risk for febrile neutropenia in patients undergoing TPF chemotherapy for head and neck squamous cell carcinoma
por: Shimanuki, Marie, et al.
Publicado: (2018)

Platelet aggregometry assay for evaluating the effects of platelet agonists and antiplatelet compounds on platelet function in vitro
por: Tsoupras, Alexandros, et al.
Publicado: (2018)

Antiplatelet Agents Inhibit the Generation of Platelet-Derived Microparticles
por: Giacomazzi, Alice, et al.
Publicado: (2016)

Variability of Platelet Reactivity on Antiplatelet Therapy in Neurointervention Procedure
por: Yi, Ho Jun, et al.
Publicado: (2019)

Platelet-Mimicking Nanosponges for Functional Reversal of Antiplatelet Agents
por: Xu, Junchao, et al.
Publicado: (2023)

Effects of Antiplatelet Drugs on Platelet-Dependent Coagulation Reactions
por: Muravlev, Ivan A., et al.
Publicado: (2023)

Platelet count as an independent risk factor for acute kidney injury induced by rhabdomyolysis
por: Wang, Di, et al.
Publicado: (2021)

Circulating small non coding RNA signature in head and neck squamous cell carcinoma
por: Martinez, Berta Victoria, et al.
Publicado: (2015)

Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma
por: Huang, Xiaomin, et al.
Publicado: (2023)

Count of platelet and mean platelet volume score: serologic prognostic factor in patients with oral squamous cell carcinoma
por: Park, Jae Woo, et al.
Publicado: (2017)

Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas
por: Ho, Won Jin, et al.
Publicado: (2018)

Methotrexate and the platelet count.
por: Ogston, D., et al.
Publicado: (1968)

Postoperative Monocyte Count Change Is a Better Predictor of Survival Than Preoperative Monocyte Count in Esophageal Squamous Cell Carcinoma
por: Song, Qian, et al.
Publicado: (2019)

Better outcome for parotid versus neck metastasis of head and neck cutaneous squamous cell carcinoma: a new report on reemerging data
por: Girardi, Fábio Muradás, et al.
Publicado: (2019)

The Ratio of ADP- to TRAP-Induced Platelet Aggregation Quantifies P2Y(12)-Dependent Platelet Inhibition Independently of the Platelet Count
por: Olivier, Christoph B., et al.
Publicado: (2016)

White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers
por: Hardy, Timothy, et al.
Publicado: (2013)

Detection of Circulating Tumor Cell Subpopulations in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Weller, Patrick, et al.
Publicado: (2014)

Circulating tumor cell analysis in locally advanced and metastatic squamous cell carcinoma of the head and neck
por: Harris, Ethan J., et al.
Publicado: (2020)

Association of circulating protein biomarkers with clinical outcomes of durvalumab in head and neck squamous cell carcinoma
por: Arends, Rosalinda, et al.
Publicado: (2021)

Circulating naïve and effector memory T cells correlate with prognosis in head and neck squamous cell carcinoma
por: Takahashi, Hideyuki, et al.
Publicado: (2021)

Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma
por: Burgener, Justin M., et al.
Publicado: (2021)

Pre-treatment circulating neutrophil count is an independent prognostic factor in oropharyngeal cancer
por: Li, Liang, et al.
Publicado: (2020)

Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease
por: Pi, Lei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rgjlbtt60go14bpsuoh94ooou4